p16 protein status and response to treatment in a prospective clinical trial (ECOG 2303) of patients with head and neck squamous cell carcinoma (HNSCC).

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. e16032-e16032 ◽  
Author(s):  
A. Psyrri ◽  
M. S. Ghebremichael ◽  
E. Pectasides ◽  
A. T. Dimou ◽  
B. Burtness ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Neck Squamous Cell Carcinoma ◽  
Prospective Clinical Trial ◽  
Response To Treatment ◽  
Protein Status ◽  
P16 Protein

Clinical utility of PET/CT in the evaluation of head and neck squamous cell carcinoma with an unknown primary: A prospective clinical trial

Head & Neck ◽  
2010 ◽  
Vol 33 (7) ◽  
pp. 935-940 ◽  
Author(s):  
Luke Rudmik ◽  
Harold Y. Lau ◽  
T. Wayne Matthews ◽  
J. Douglas Bosch ◽  
Reinhard Kloiber ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Clinical Utility ◽  
Neck Squamous Cell Carcinoma ◽  
Prospective Clinical Trial ◽  
Unknown Primary ◽  
Pet Ct

Predicting unreported clinical trial efficacy using an ex-vivo tumor platform: Pembrolizumab+pt+5-FU vs. extreme in recurrent head and neck squamous cell carcinoma.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. e18042-e18042
Author(s):  
Munisha Smalley ◽  
Saravanan Thiyagarajan ◽  
Biswanath Majumder ◽  
Nandini Pal Basak ◽  
Abhishek Basu ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Ex Vivo ◽  
Neck Squamous Cell Carcinoma ◽  
Recurrent Head
Sign in / Sign up

Export Citation Format

Share Document